2026· Biocell (Mendoza)· pp. 1-10· 0 citations· 293 references
TL;DR
The gut microbiota, oxidative stress, and extracellular vesicles (EVs) form an interdependent triad essential for gastrointestinal homeostasis and systemic health and integrated multi-omics and standardized EV profiling are needed for precision medicine approaches.
Abstract
: The gut microbiota, oxidative stress, and extracellular vesicles (EVs) form an interdependent triad essential for gastrointestinal homeostasis and systemic health. This narrative review summarizes the molecular crosstalk among these components in inflammation and disease. Literature was retrieved from PubMed and Scopus using relevant keywords and reference screening. Gut microbes regulate redox balance through metabolites such as short-chain fatty acids and modulation of host reactive oxygen species (ROS) production via mitochondrial pathways and nicotinamide adenine dinucleotide phosphate (NADPH) oxidase. Dysbiosis has been associated with excessive ROS generation, impaired antioxidant defenses, and activation of redox-sensitive signaling pathways, including nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κ B), NOD-like receptor pyrin domain containing 3 (NLRP3) inflammasome, and mitogen-activated protein kinase (MAPK), contributing to inflammatory and metabolic diseases. EVs act as mediators of host-microbe communication by transferring bioactive cargo that may influence oxidative stress, immune responses, and epithelial integrity. Host-derived EVs, shaped by redox status, may further contribute to systemic inflammation associated with chronic diseases. Therapeutic strategies include microbiota modulation, antioxidants, nuclear factor erythroid 2-related factor 2 (Nrf2) activators, NADPH oxidase inhibitors, and EV-based interventions. Integrated multi-omics and standardized EV profiling are needed for precision medicine approaches.
These investigations emphasize the emerging mechanistic significance of microbiota-induced modulation of mitochondrial function in host defense mechanisms, thereby illuminating potential therapeutic approaches that focus on microbial composition, mitochondrial dynamics, and inflammasome signaling to alleviate infectiou...
Xinxing Lu, Wenbin Sun, Daowei Zhang et al.· Frontiers in Cellular and In...· 1 citation
It is proposed that microbial metabolites represent a context-dependent mechanism for modulating Nrf2 activity in inflammation-associated cancers, with important implications for translational and precision medicine approaches.
My-Lan Pianka, Xuelei Zhang, C. Stein-Thoeringer· Gut microbes· 0 citations
This review delineates how the canonical UPR sensors transduce metabolic stress into pro-inflammatory signaling cascades and discusses the organ-specific consequences of ERS in the liver, pancreas, adipose tissue, vascular endothelium, and hypothalamus, highlighting how this stress sustains a self-reinforcing cycle of...
B. Wen, Xiaojin Wu, Kaiying Zhang et al.· Pharmacological Research· 0 citations
Understanding the BEV–gut microbiome–circadian axis provides new mechanistic insights into host–microbe communication and highlights BEVs as promising postbiotic candidates for restoring immune–metabolic homeostasis and developing next-generation microbiome-targeted therapeutics.
Hyejin Choi, S. Oh, Young-Hun Kim· Journal of Microbiology and...· 0 citations
Gut microbiota exert core regulatory effects on systemic metabolic homeostasis and immune balance under physiological and pathological conditions. Marked gut dysbiosis occurs during the progression of chronic kidney disease (CKD), characterized by abnormal enrichment of opportunistic pathogens and depletion of benefici...
Qian-Wei Wang, Jiahe Zhang, Ruiyan Chen et al.· Frontiers in Pharmacology· 0 citations
Current evidence represents the microbiota–mitochondria axis as a one of the promising mechanistic and therapeutic targets for neurodegenerative and ocular diseases, however, most therapeutic evidence discussed in this review is derived from preclinical studies, with relatively limited clinical validation.
Puneet K. Samaiya, Akshat Agrawal, Shrija Kesharwani et al.· Frontiers in Pharmacology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.